348 related articles for article (PubMed ID: 16178016)
1. No increase of calcitonin gene-related peptide in jugular blood during migraine.
Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
[TBL] [Abstract][Full Text] [Related]
2. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
Sarchielli P; Alberti A; Vaianella L; Pierguidi L; Floridi A; Mazzotta G; Floridi A; Gallai V
Headache; 2004; 44(10):961-8. PubMed ID: 15546258
[TBL] [Abstract][Full Text] [Related]
3. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
[TBL] [Abstract][Full Text] [Related]
4. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
5. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide in cervicogenic headache.
Frese A; Schilgen M; Edvinsson L; Frandsen E; Evers S
Cephalalgia; 2005 Sep; 25(9):700-3. PubMed ID: 16109051
[TBL] [Abstract][Full Text] [Related]
7. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack.
Juhasz G; Zsombok T; Jakab B; Nemeth J; Szolcsanyi J; Bagdy G
Cephalalgia; 2005 Mar; 25(3):179-83. PubMed ID: 15689192
[TBL] [Abstract][Full Text] [Related]
9. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J
Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.
Tfelt-Hansen P; Le H
J Headache Pain; 2009 Jun; 10(3):137-43. PubMed ID: 19330286
[TBL] [Abstract][Full Text] [Related]
11. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P
Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks.
Sarchielli P; Alberti A; Coppola F; Baldi A; Gallai B; Floridi A; Floridi A; Capocchi G; Gallai V
Cephalalgia; 2004 Aug; 24(8):623-30. PubMed ID: 15265050
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.
Hansen JM; Thomsen LL; Olesen J; Ashina M
Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks.
Sarchielli P; Alberti A; Codini M; Floridi A; Gallai V
Cephalalgia; 2000 Dec; 20(10):907-18. PubMed ID: 11304026
[TBL] [Abstract][Full Text] [Related]
15. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
Goadsby PJ; Edvinsson L
Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
[TBL] [Abstract][Full Text] [Related]
16. Reduced levels of calcitonin gene-related peptide (CGRP) but not substance P during and after treatment of severe hypertension in man.
Edvinsson L; Ekman R; Thulin T
J Hum Hypertens; 1989 Aug; 3(4):267-70. PubMed ID: 2477545
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide and size of the atrial septal defect in new-onset migraine after transcatheter closure: results of a preliminary study.
Wei SH; Fan PC; Kuo PH; Chiou LC; Wang JK
Headache; 2012 Jun; 52(6):985-92. PubMed ID: 22486257
[TBL] [Abstract][Full Text] [Related]
18. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
Ramón C; Cernuda-Morollón E; Pascual J
Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
[TBL] [Abstract][Full Text] [Related]
20. Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF.
Hoffmann J; Wecker S; Neeb L; Dirnagl U; Reuter U
Cephalalgia; 2012 Jul; 32(9):659-67. PubMed ID: 22652383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]